Holmusk Expands NeuroBlu Dataset to 46 Million Patients with Neurology and Biomarker Data
Holmusk has expanded its NeuroBlu platform to include data from more than 46 million de-identified patients, adding new neurological health systems, structured biomarker information, and validated outcomes across multiple disease areas.